Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

October 31, 2007

Study Completion Date

March 31, 2012

Conditions
Brain and Central Nervous System TumorsUnspecified Childhood Solid Tumor, Protocol Specific
Interventions
DRUG

valproic acid

Trial Locations (17)

10032

Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, New York

13210

SUNY Upstate Medical University Hospital, Syracuse

55455

University of Minnesota Children's Hospital - Fairview, Minneapolis

55905

Mayo Clinic Cancer Center, Rochester

60614

Children's Memorial Hospital - Chicago, Chicago

92868

Children's Hospital of Orange County, Orange

94305

Stanford Comprehensive Cancer Center - Stanford, Stanford

98105

Children's Hospital and Regional Medical Center - Seattle, Seattle

20010-2970

Children's National Medical Center, Washington D.C.

46202-5289

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis

02115

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston

45229-3039

Cincinnati Children's Hospital Medical Center, Cincinnati

97239-3098

Oregon Health & Science University Cancer Institute, Portland

19104-9786

Children's Hospital of Philadelphia, Philadelphia

77030-2399

Baylor University Medical Center - Houston, Houston

M5G 1X8

Hospital for Sick Children, Toronto

H3T 1C5

Hopital Sainte Justine, Montreal

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK

NCT00107458 - Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors | Biotech Hunter | Biotech Hunter